BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6509454)

  • 1. Use of decline in D-xylose absorption to predict infection following intensive chemotherapy.
    Pegues DA; Daly KM; Larson RA
    Cancer Treat Rep; 1984 Dec; 68(12):1489-91. PubMed ID: 6509454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of intestinal absorption in patients treated with cytostatic chemotherapy].
    Hürter T; Reis HE; Borchard F
    Z Gastroenterol; 1989 Oct; 27(10):606-10. PubMed ID: 2588735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-xylose absorption test. A pharmacokinetic and statistical study].
    Huguenin P; Cochet B; Balant L; Loizeau E
    Schweiz Med Wochenschr; 1978 Feb; 108(6):206-14. PubMed ID: 622549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D(+)-xylose absorption test in the horse. A clinical study.
    Dietz HH
    Nord Vet Med; 1981 Mar; 33(3):114-20. PubMed ID: 7312585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of D-xylose absorption in normal subjects and in patients with chronic renal failure.
    Craig RM; Murphy P; Gibson TP; Quintanilla A; Chao GC; Cochrane C; Patterson A; Atkinson AJ
    J Lab Clin Med; 1983 Mar; 101(3):496-506. PubMed ID: 6827177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-xylose test for the evaluation of intestinal absorption following esophagoplasty].
    Piegza S; Rosińska T; Markowska A
    Pol Przegl Chir; 1974 Dec; 46(12):1651-6. PubMed ID: 4445060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intestinal absorption of D-xylose. II. Relationship between blood concentration of D-xylose and its dose].
    Tomaszewski L; Zalewski T; Radzikowski A; Rozental M
    Pediatr Pol; 1973; 48(10):1203-16. PubMed ID: 4760695
    [No Abstract]   [Full Text] [Related]  

  • 8. Digestion of bentiromide and absorption of xylose in healthy cats and absorption of xylose in cats with infiltrative intestinal disease.
    Hawkins EC; Meric SM; Washabau RJ; Feldman EC; Turrel JM
    Am J Vet Res; 1986 Mar; 47(3):567-9. PubMed ID: 3485942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeled acetate to assess intestinal absorption in critically ill patients.
    Chioléro RL; Revelly JP; Berger MM; Cayeux MC; Schneiter P; Tappy L
    Crit Care Med; 2003 Mar; 31(3):853-7. PubMed ID: 12626996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-xylose test in the examination of the absorption disorders in children].
    Filipović D; Subotić Z; Vulović D; Banićević M
    Srp Arh Celok Lek; 1972 Mar; 100(3):345-51. PubMed ID: 5048029
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cytostatics on the intestinal absorption of D-xylose in patients with malignant lymphoma.
    Beró T; Jávor T
    Acta Med Hung; 1983; 40(4):247-50. PubMed ID: 6674917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal absorption mechanism diagnosed by means of D-xylose administration].
    Zalewski T; Radzikowski A; Rozental M
    Pediatr Pol; 1973 Apr; 48(4):411-8. PubMed ID: 4703380
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variations in intestinal absorption. II. The age factor; curves after oral xylose loading].
    Ciampolini M; Adami-Lami Conti C; Muzzarelli D; Falcini F
    Minerva Dietol Gastroenterol; 1977; 23(2):67-70. PubMed ID: 917318
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of influence of etretinate on the intestinal absorption of D-xylose and of phytomenadione (vitamin K1) as representatives of hydrophilic and lipophilic compounds.
    Hartmann D; Crevoisier C; Dubach UC; Forgo I; Heizmann P
    Arzneimittelforschung; 1987 Dec; 37(12):1392-6. PubMed ID: 3449069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination of intestinal absorption. Critical review of the D-xylose test].
    Aparisi-Quereda L; Rodrígo-Gómez JM; Guix-García J; Serra-Desfilis MA; del Olmo Puchalt JA; Wassel AH
    Rev Esp Enferm Apar Dig; 1977 Apr; 50(2):197-230. PubMed ID: 866783
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence, prognosis and prevention of septicaemias in patients under treatment for acute leukaemia (author's transl)].
    Gastaut JA; Maraninchi D; Bagarry Liegey D; Lejeune C; Novakovitch G; Sebahoun G; Meyer G; Carcassonne Y
    Nouv Presse Med; 1982 Feb; 11(8):579-82. PubMed ID: 7070992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D-xylose absorption test in different ethnic groups.
    Cook GC
    Trop Geogr Med; 1979 Mar; 31(1):93-7. PubMed ID: 483377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
    Bow EJ; Gallant G; Williams GJ; Woloschuk D; Shore TB; Rubinger M; Schacter BA
    Cancer; 1998 Oct; 83(7):1344-54. PubMed ID: 9762935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prechemotherapy dental treatment to prevent bacteremia.
    Greenberg MS
    NCI Monogr; 1990; (9):49-50. PubMed ID: 2342595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.